Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
Cipla
McKinsey
Chinese Patent Office
Healthtrust
Cantor Fitzgerald
Boehringer Ingelheim
Johnson and Johnson
Dow

Generated: January 22, 2018

DrugPatentWatch Database Preview

Bretylium tosylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bretylium tosylate and what is the scope of bretylium tosylate patent protection?

Bretylium tosylate
is the generic ingredient in four branded drugs marketed by Abraxis Pharm, Astrazeneca, Eurohlth Intl Sarl, Hospira, Intl Medication, Luitpold, West-ward Pharms Int, Abbott, B Braun, Baxter Hlthcare, and Hospira Inc, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for bretylium tosylate.
Summary for bretylium tosylate
Medical Subject Heading (MeSH) Categories for bretylium tosylate

US Patents and Regulatory Information for bretylium tosylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019008-002 Apr 29, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019121-001 Apr 29, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019837-002 Apr 12, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 070891-001 Jul 26, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 071153-001 Aug 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 071151-001 Aug 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira BRETYLOL bretylium tosylate INJECTABLE;INJECTION 017954-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott BRETYLIUM TOSYLATE IN DEXTROSE 5% bretylium tosylate INJECTABLE;INJECTION 019005-001 Apr 29, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019837-001 Apr 12, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 070119-001 Apr 29, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Covington
Healthtrust
Express Scripts
Argus Health
Fish and Richardson
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot